Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-24-054781

Chief Financial Officer acquired 140,040 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Gabay Avraham Chief Financial Officer 2024-06-21 Grant or award +140,040 0 D
Loading xslF345X05/ownership.xml…